ArQule Stock Price (NASDAQ:ARQL)

Add to My Stocks
$5.02 $0.02 (0.4%) ARQL stock closing price Sep 18, 2018 (Closing)
Prev Close* : $5.04
Market Cap:
Day Low: $4.93
52 Week Low: $0.97
Open: $5.03
Volume: -
Day High: $5.19
52 Week High: $7.21

Latest Stock Market News

Latest Articles

ArQule News - From Partners

ARQL Stockcharts

View ARQL PE ratio, PS ratio stocks charts and compare with peers.
ARQL Chart
Note: Compare ArQule stock price history with the index and industry peers.

ArQule Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

ArQule Returns

(return on equity)

ArQule Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

ARQL Industry Peers

Company Price Change (%)
Glycomimetics (GLYC)14.580.67 (4.82%)
Vitae Pharma (VTAE)210 (0%)
Agios Pharma (AGIO)71.670.4 (0.56%)
Aveo Pharmaceuticals (AVEO)2.870.01 (0.35%)
Celsion (CLSN)2.830.06 (2.17%)
Celgene (CELG)87.610.41 (0.47%)
Aveo Pharmaceuticals (AVEO)2.870.01 (0.35%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

ArQule, Inc. Stock News - Partner Headlines

ArQule Financial Statements

income statement20172016201520142013
Net Sales or Revenues-4.7M11.23M11.25M15.91M
Net Income-29.2M-22.71M-13.77M-23.39M-24.6M
Total Operating Expense27.01M27.6M25.39M35.52M41.03M
View ArQule income statement
balance sheet20172016201520142013
Total Assets48.9M32.38M40M63.39M98.17M
Total Liabilities25.87M8.7M10.82M22.84M37.55M
Shareholders Equity23.02M23.68M29.17M40.54M60.62M
View ArQule balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities1.32M-2.23M-10.76M-12.48M-15.42M
Net Cash from (used by) Operating Activities-25.17M-22.93M-22.16M-31.78M-33.68M
Increase (Decrease) in Prop Plant And Equipment--0.01M-0.01M--
View ArQule cash flow statement

ArQule Stock Message Board

ArQule stock lost 0.4%, and the last close price as of Sep 18, 2018 is $5.02 for ARQL stock. The total market value as denoted by $548.44M for ArQule, is the market value of the company's outstanding shares. ArQule valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that ArQule is worth a lot, it will most likely be reflected in an inflated ArQule stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 1,084,025 shares were traded with a closing stock price of $5.02 as of Sep 18, 2018, as can be seen from ArQule stock quote. One can view ArQule stock chart to follow the stock price trend. ArQule paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of ARQL, view ArQule stock price history.